UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced new leadership. Dr. Edgar Rodriguez-Lebron, co-founder, will serve as president and chairman of the Board of Directors. Co-founders and scientific advisors, Drs. Ken Warrington and Coy Heldermon, will round out the additions to the board. The company … Continue reading Lacerta Therapeutics Strengthens Its Position in the AAV Gene Therapy Space With New Leadership